No earnings within 2 weeks of this transaction.
| Insider | Flomenberg Neal |
|---|---|
| Title | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026. |
| Transaction Date | Mar 10, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 17, 2026 |
| Shares Sold | 19 |
| Price per Share | $7.75 |
| Total Value | $147.25 |
| Shares Owned After | 77,893 |
| Derivative | No |
| Accession Number | 0001123292-26-000465 |
| Document | View SEC Filing |